Trials / Completed
CompletedNCT01727895
Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans
Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans, a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- Male
- Age
- 18 Years – 36 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to test wether orally administered Beta-glucan has systemic effects in humans.
Detailed description
The immunostimulatory properties of mushrooms have been recognized for centuries, and "medicinal" mushrooms are still widely used in alternative medicine all over the world. Although a number of fungal components have been implicated in these properties, Beta-glucans have attracted the most attention. However, although Beta-glucans are widely used as a health food supplement, their immunomodulatory effects after administration in humans have not yet been determined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Beta-glucan (Glucan #300®) |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2012-11-16
- Last updated
- 2014-07-31
- Results posted
- 2014-07-31
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01727895. Inclusion in this directory is not an endorsement.